CrossrefInfokarte
Effects of the continuous subcutaneous infusion of foslevodopa-foscarbidopa on swallowing in patients with Parkinson’s disease
Clinical Parkinsonism & Related Disorders · 2025 · 13 · 100378
DOI: 10.1016/j.prdoa.2025.100378 ↗Abstract
Kein Abstract verfügbar.
EUVIMED